{
Fresenius Kabi AG

Companies

}
001122334455554433221100
001122334455554433221100

neostigmine methylsulfate injection market growth driven by chronic conditions and surgeries

The global Neostigmine Methylsulfate Injection Market, valued at $156.54 million in 2022, is projected to reach $228.43 million by 2031, growing at a CAGR of 4.4%. The rise in chronic conditions like myasthenia gravis and increased surgical procedures are driving market expansion, particularly in North America and emerging markets. Key players include Pfizer, Fresenius Kabi, and Hikma Pharmaceuticals, with ongoing developments in combination therapies enhancing treatment options.
openPR.com
United States Dollar Fresenius Kabi AG SUN Pharmaceutical Industries Ltd. Hikma Pharmaceuticals PLC Pfizer Inc. Bausch Health Companies Inc. Endo International Ltd. Baxter International Inc. FRA KOR GBR ESP USA DEU ITA CAN CHN IND BRA ARG ZAF JPN MEX Mylan Nv Show more
Healthcare, Market Report
08:28 23.12.2024

growth prospects in the food for special medical purpose market

The Food for Special Medical Purpose market is poised for growth, driven by the rise in chronic illnesses and an aging population, particularly in Asia Pacific and Europe. Key players include Nestle, Danone Nutricia, and Abbott, with significant investments in R&D despite high costs and regulatory challenges. The market focuses on tailored nutritional solutions for infants, adults, and the elderly, reflecting evolving dietary needs.
openPR.com
United States Dollar Fresenius Kabi AG Targeted Medical Pharma, Inc. Danone Nutricia SL Nestlé S.A. Bayer AG Ajinomoto Co., Inc. AUT CHE JPN ESP USA DEU Nidhi Bhawsar Show more
Healthcare, Market Report
18:18 20.12.2024

Global Generic Pharmaceuticals Market Sees Growth in Simple Generics and Biosimilars

India's "Pharmaceuticals Mission" aims to boost generic production, with simple generics leading the market due to cost-effectiveness and ease of manufacturing. Cardiovascular diseases drive demand, while small molecules dominate product types. Retail pharmacies remain the preferred distribution channel, and key players like Cipla and Teva are expanding their offerings.
GlobeNewswire News Room
United States Dollar Euro Fresenius Kabi AG Sanofi Aspen Pharmacare Holdings Ltd Sun Pharmaceuticals, Ltd. Aurobindo Pharma Limited Glenmark Pharmaceuticals Limited Pfizer Inc. Lupin Limited Dr. Reddy's Laboratories Limited Zydus Lifesciences Limited Teva Pharmaceuticals, Inc. Viatris Inc. Novartis AG Hikma Cipla Limited IND USA Show more
Healthcare, Market Report
16:30 04.12.2024

healthcare consumables market poised for rapid growth driven by sustainability trends

The healthcare consumables market is projected to grow from $281.63 billion in 2023 to $466.65 billion by 2028, driven by rising hospital admissions, chronic disease prevalence, and the adoption of biodegradable products. Major players are focusing on eco-friendly innovations to enhance sustainability and meet increasing healthcare demands.
openPR.com
Nipro Corporation Medi-Plast Ltd. Fresenius Kabi AG Smith & Nephew plc Alcon Laboratories Inc. B. Braun Melsungen AG Zimmer Biomet Holdings, Inc. Invacare Corporation BioLife Solutions, Inc. Boston Scientific Corporation Johnson & Johnson Siemens Healthineers AG Abbott Laboratories Cardinal Health, Inc. GE HealthCare Technologies Inc. Coloplast A/S Philips Healthcare DexCom, Inc. Ortho-Clinical Diagnostics Inc. Terumo Corporation AngioDynamics, Inc. Becton Dickinson and Company (BD) Stryker Corporation Hollister Incorporated Hologic, Inc. 3M Company Brian Johnson Show more
Healthcare, Market Report
11:38 28.11.2024

growth and trends in the us compounding pharmacy market through 2033

The U.S. compounding pharmacy market is projected to grow from $5.8 billion in 2023 to $10.1 billion by 2033, with a CAGR of 5.7%. The adult segment leads revenue, driven by preferences for personalized medications, while non-sterile products dominate due to their adaptability to patient needs. Key growth factors include rising cancer prevalence, drug shortages, and an aging population, despite challenges from warnings about sterile compounds.
Spherical Insights
United States Dollar Athenex Inc. Fagron B.V. B. Braun Melsungen AG Clinigen Group plc Fresenius Kabi AG USA Dougherty Pharmacy Fresenius Kabi B Braun Melsungen Clinigen Group PLC Athenex Pharma Solutions Show more
Healthcare, Market Report
09:00 08.11.2024

global bile duct cancer market analysis and growth prospects through 2030

The bile duct cancer market is expanding, driven by a shortage of specialists and healthcare system challenges in developing countries. In 2021, North America led the market with a 37.1% share and $185.4 billion in revenue, fueled by increased R&D and rising cancer prevalence. The Asia-Pacific region is projected to grow the fastest through 2030, supported by awareness programs and private investments.
Spherical Insights
United States Dollar Glaxosmithkline plc Pfizer Inc. Novartis AG Fresenius Kabi AG AbbVie Inc. RUS GBR ITA ESP USA KOR SAU JPN MEX ARE ZAF BRA ARG CHN QAT AUS IND DEU CAN Eli Lilly GlaxoSmithKline plc Pfizer Inc. Novartis AG AbbVie Inc. Show more
Healthcare, Market Report
22:25 28.10.2024
Trending
Subcategory
Corporate News Stock Market Updates Industry Trends Finance Mergers & Acquisitions Global Financial Events Banking Regulations Retail and Consumer Goods Market Analysis and Predictions CEO Changes Global Trade Developments Industry Mergers & Acquisitions Energy Sector Developments Startups & Entrepreneurship Supply Chain Management Financial Scams and Security Government Policies Central Bank Actions Government Economic Policies Domestic Politics Workplace Trends
Countries:
USA CHN IND DEU CHE FRA GBR AUT ITA RUS JPN CAN AUS SGP ARE HKG VNM TWN NLD UKR
Companies:
Tesla, Inc. Barclays PLC BNP Paribas SA JPMorgan Chase & Co. Apple Inc. Raiffeisen Bank International AG Deutsche Bank RV Global PP Bank of America Corporation UBS Group AG NVIDIA Corporation Morgan Stanley Capital One Financial Corporation The Goldman Sachs Group, Inc. Citigroup Inc. Berkshire Hathaway Inc. Amazon.com, Inc. SpaceXCoin USD Commerzbank AG Credit Suisse Real Estate Fund Siat Wells Fargo & Company
Currencies:
United States Dollar Euro Chinese Yuan Indian Rupee Swiss Franc British Pound Sterling Vietnamese Đồng Japanese Yen Australian Dollar Hong Kong Dollar United Arab Emirates Dirham Russian Ruble Singapore Dollar South Korean Won Thai Baht Norwegian Krone Danish Krone Swedish Krona Ghanaian Cedi Canadian Dollar
People:
Elon Musk Donald Trump Warren Buffett Scott Bessent Jerome Powell Jean-Laurent Bonnafé Andreas Schneemann Eva Fugger Oleg Deripaska Peter Navarro Joe Biden Carsten Fritsch Dan Ives Howard Lutnick Vaibhav Taneja Thomas Müller Karoline Leavitt Bernie Ahkong Hubert Dichtl Susy Tibaldi

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.